http___www.index.hr_Vijesti_clanak_gen-odgovoran-za-nastanak-parkinsonove-i-alzheimerove-bolesti_166586.aspx_1.xml
1.1 2.1 3.1 4.1 5.1 6.1 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 15.1 16.1
Busting the myth, a study has recently revealed that coffee"drinking coffee may not reduce Parkinson's disease" symptoms of Parkinson's disease. Parkinson's disease is a disorder of the central nervous system that affects movement, often including tremors. The results indicated that caffeine cannot be recommended as therapy for movement Parkinson's disease symptoms of Parkinson's disease. Researchers from McGill University in Montreal, Canada showed that coffee may not relieve the Parkinson's disease symptoms of Parkinson's disease. A more in-depth investigation has shown that the beverage did nothing to alleviate sufferers' crippling symptoms. Study author Dr Ronald Postuma said that caffeine, which is so safe and inexpensive, has been linked to a reduced risk of developing Parkinson's. "So, it was exciting to think that it could possibly help people who already have the disease," Postuma added. The team analysed 121 people with an average age of 62, who had been diagnosed with Parkinson's for an average of four years. Of those, half were given a 200-milligram capsule of caffeine twice daily, once in the morning and once after lunch, the equivalent of three cups of coffee per day, while the other half were given placebo capsules. To help them adjust to the caffeine, the dose was increased slowly, starting with placebo and reaching 200 milligrams at week nine. The study participants were followed for six to 18 months. The findings indicated there was no improvement in movement symptoms for people who had taken the caffeine capsules compared to those who took the placebo capsules. There was also no difference in quality of life. Dr Postuma stated that while previous study showed possible improvement in symptoms but that study was shorter, so it's possible that caffeine may have a short-term benefit that quickly dissipates. The research appears in online issue of Neurology. -ANI
1.1 2.1 3.1 4.1 5.1 6.1 7.1
Američki su istraživači pronašli gen koji utječe na to kada će se javiti prvi simptomi Parkinsonove i Alzheimerove bolesti. "Shvatimo li kakvu ulogu taj gen ima u Alzheimerovoj i u Parkinsonovoj bolesti, moći ćemo odgoditi početak pojave simptoma", izjavila je Yi-Ju Li, član istraživačke skupine iz središta za ljudsku genetiku na sveučilištu Duke u Durhamu (Sjeverna Karolina). Prema njezinim riječima, i najmanja odgoda početka ovih dviju bolesti može povoljno djelovati na rizične osobe. Istraživači su ispitali više od 1.700 osoba oboljelih od Alzheimerove i 600 osoba oboljelih od Parkinsonove bolesti i usporedili ih s osobama koje ne boluju od tih bolesti. Parkinsonova bolest jedna je od najčešćih neuroloških bolesti, a često je prati gubitak intelektualnih sposobnosti. Alzheimerova bolest je kronična neurodegenerativna bolest koje se prvi simptomi najčešće očituju u gubitku pamćenja nedavnih događaja. (Hina) vrad dgk